27349853

Xiao H

2016

Metformin is a novel suppressor for transforming growth factor (TGF)-?1.

27350232

Safier LZ

2016

Use of anti-M?llerian hormone testing during ovarian reserve screening to identify women at risk of polycystic ovary syndrome.

27351028

Layegh P

2016

Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and non-obese PCOS patients.

27351893

Kudesia R

2016

Elevated Prevalence of Polycystic Ovary Syndrome and Cardiometabolic Disease in South Asian Infertility Patients.

27354380

Li Q

2016

Genetic variations in the 3'-untranslated region of SLC18A2 are associated with serum FSH concentration in polycystic ovary syndrome patients and regulate gene expression in vitro.

27358825

Pruksananonda K

2016

Epigenetic modification of long interspersed elements-1 in cumulus cells of mature and immature oocytes from patients with polycystic ovary syndrome.

27358832

Seok HH

2016

Application of serum anti-M?llerian hormone levels in selecting patients with polycystic ovary syndrome for in vitro maturation treatment.

27365543

Fischer D

2016

Avoiding OHSS: Controlled Ovarian Low-Dose Stimulation in Women with PCOS.

27367829

Gu BX

2016

Abnormal expression of TLRs may play a role in lower embryo quality of women with polycystic ovary syndrome.

27368923

Vigneri R

2016

Insulin, insulin receptors, and cancer.

27375552

Huang-Doran I

2016

Genetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary Syndrome.

27375725

Inan C

2016

Correlation between ovarian morphology and biochemical and hormonal parameters in polycystic ovary syndrome.

27377844

Koseoglu SB

2016

Impaired olfactory function in patients with polycystic ovary syndrome.

27381237

Yousuf SD

2017

Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-? Levels in Women with Polycystic Ovary Syndrome: A Pilot Study.

27385973

Hossein-Rashidi B

2016

Recombinant FSH Compared to Clomiphene Citrate as the First-Line in Ovulation Induction in Polycystic Ovary Syndrome Using Newly Designed Pens: A Randomized Controlled Trial.

27386819

Huang S

2016

Fractalkine restores the decreased expression of StAR and progesterone in granulosa cells from patients with polycystic ovary syndrome.

27387253

Lizneva D

2016

Androgen excess: Investigations and management.

27392736

Ksouda K

2009

[Polycystic Ovary Syndrome Induced by Valproic Acid. A Case Report].

27401369

Ding T

2016

Diagnosis and management of polycystic ovary syndrome in the UK (2004-2014): a retrospective cohort study.

27402910

Santoro N

2016

Fertility-related quality of life from two RCT cohorts with infertility: unexplained infertility and polycystic ovary syndrome.

27403074

Kalem MN

2016

Effect of body mass index and age on in vitro fertilization in polycystic ovary syndrome.

27406030

Hwang YI

2016

Fertility of patients with polycystic ovary syndrome undergoing in vitro fertilization by age.

27406348

McCartney CR

2016

CLINICAL PRACTICE. Polycystic Ovary Syndrome.

27407136

Cao SF

2017

Effects of Exercise Intervention on Preventing Letrozole-Exposed Rats From Polycystic Ovary Syndrome.

27412249

Rowlands IJ

2016

Young women's psychological distress after a diagnosis of polycystic ovary syndrome or endometriosis.

27412270

Chung J

2016

Health-related quality-of-life questionnaire for women with polycystic ovary syndrome: a Chinese translation and validation study.

27412301

Rutkowska AZ

2016

Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?

27412368

Mahalingaiah S

2016

Association of prenatal and early life exposure to tetrachloroethylene (PCE) with polycystic ovary syndrome and other reproductive disorders in the cape cod health study: A retrospective cohort study.

27418215

G?owi?ska A

2016

Determinants of emotional problems and mood disorders in women with polycystic ovary syndrome.

27419327

Williams T

2016

Diagnosis and Treatment of Polycystic Ovary Syndrome.

27420145

Fux Otta C

2016

[Polycystic ovary sindrome: impact on reproductive and material fetal health].

27423183

De Leo V

2016

Genetic, hormonal and metabolic aspects of PCOS: an update.

27424378

Mahmoud SA

2016

Adverse Long-term Metabolic and Endometrial Consequences in Women with Polycystic Ovarian Syndrome: A Report of Two Cases.

27424881

Fr?ssing S

2017

Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study.

27425146

Li S

2016

The epigenomics of polycystic ovarian syndrome: from pathogenesis to clinical manifestations.

27425379

Elci E

2017

Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries.

27425581

Ding N

2016

Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome: a systematic review and meta-analysis.

27426018

Rudnicka E

2016

Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome - a new insight.

27426125

Saydam BO

2016

Gut-Brain Axis and Metabolism in Polycystic Ovary Syndrome.

27426126

Abbott DH

2016

Translational Insight Into Polycystic Ovary Syndrome (PCOS) From Female Monkeys with PCOS-like Traits.

27428059

Javed A

2016

Polycystic ovary syndrome in adolescents: a review of past year evidence.

27428219

Zhu X

2016

The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments.

27429113

Draveck? I

2016

The effect of alfacalcidiol and metformin on phenotype manifestations in women with polycystic ovary syndrome - a preliminary study.

27432836

Heida KY

2016

Cardiovascular risk management after reproductive and pregnancy-related disorders: A Dutch multidisciplinary evidence-based guideline.

27434652

Gursoy Calan O

2016

Increased adipsin is associated with carotid intima media thickness and metabolic disturbances in polycystic ovary syndrome.

27437203

Mishra S

2016

Hypovitaminosis D and Associated Cardiometabolic Risk in Women with PCOS.

27445197

Quinn MM

2016

Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk.

27449565

Chen TS

2017

Steroidogenic enzymes of adipose tissue in modulation of trivalent chromium in a mouse model of PCOS.

27449893

Reyes-Mu?oz E

2016

Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical-biochemical characteristics among infertile Mexican women with polycystic ovary syndrome: a cross-sectional study.

27450187

Riley JK

2016

Is there a role for diet in ameliorating the reproductive sequelae associated with chronic low-grade inflammation in polycystic ovary syndrome and obesity?

27450358

Armanini D

2016

Spironolactone in the treatment of polycystic ovary syndrome.

27454463

Jones AV

2016

Genome-wide association analysis of pain severity in dysmenorrhea identifies association at chromosome 1p13.2, near the nerve growth factor locus.

27456547

Sim SY

2016

Polycystic ovary syndrome in type 2 diabetes: does it predict a more severe phenotype?

27457114

Dhesi AS

2016

Metabolic screening in patients with polycystic ovary?syndrome is largely underutilized among obstetrician-gynecologists.

27459230

Rosenfield RL

2016

The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

27459314

Hao M

2016

Overexpression of Lnk in the Ovaries Is Involved in Insulin Resistance in Women With Polycystic Ovary Syndrome.

27459445

Chavarro JE

2016

Contributions of the Nurses' Health Studies to Reproductive Health Research.

27459523

George JT

2016

Neurokinin B Receptor Antagonism in Women With Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial.

27461373

Zhang Y

2016

Molecular characterization of insulin resistance and glycolytic metabolism in the rat uterus.

27464726

Dimitriadis GK

2016

Polycystic Ovary Syndrome as a Proinflammatory State: The Role of Adipokines.

27465377

Schoenaker DA

2016

Quantifying the mediating effect of body mass index on the relation between a Mediterranean diet and development of maternal pregnancy complications: the Australian Longitudinal Study on Women's Health.

27468791

Csenteri OK

2017

The role of hyperinsulinemia as a cardiometabolic risk factor independent of obesity in polycystic ovary syndrome.

27470958

Hu WH

2016

[Expression and regulation of CD36 mRNA in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome].

27471004

Marti N

2017

Genes and proteins of the alternative steroid backdoor pathway for dihydrotestosterone synthesis are expressed in the human ovary and seem enhanced in the polycystic ovary syndrome.

27472012

Garvey WT

2016

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITYEXECUTIVE SUMMARYComplete Guidelines available at https://www.aace.com/publications/guidelines.

27472811

Ramos FK

2016

Quality of Life in Women with Polycystic Ovary Syndrome after a Program of Resistance Exercise Training.

27473078

Polak K

2017

New markers of insulin resistance in polycystic ovary syndrome.

27473350

Maas KH

2016

Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome.

27478827

Yu Q

2016

Subclinical Hypothyroidism in PCOS: Impact on Presentation, Insulin Resistance, and Cardiovascular Risk.

27479317

?n B

2016

Evaluation of hs-CRP and visseral adiposity index in patients with policystic ovary syndrome by clinical and laboratory findings.

27483558

Bjelica A

2016

Comparison of the efficiency of clomiphene citrate and letrozole in combination with metformin in moderately obese clomiphene citrate-resistant polycystic ovarian syndrome patients.

27483702

P?v?leanu I

2016

TREATMENT OF METABOLIC ALTERATIONS IN POLYCYSTIC OVARY SYNDROME.

27484441

Sadeghi A

2017

Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials.

27484772

Alebi? M?

2016

Metabolic implications of menstrual cycle length in non-hyperandrogenic women with polycystic ovarian morphology.

27487421

Rice T

2016

Polycystic Ovary Syndrome and Obsessive-Compulsive Disorder: Interactions and Psychopharmacological Considerations.

27487583

Tam?s T

2016

[Not Available].

27488697

Jacob L

2016

Caesarean section and its impact on fertility and time to a subsequent pregnancy in Germany: a database analysis in gynecological practices.

27488699

Gao J

2016

The association of DENND1A gene polymorphisms and polycystic ovary syndrome risk: a systematic review and meta-analysis.

27489079

Zhang R

2017

Oxidative stress status in Chinese women with different clinical phenotypes of polycystic ovary syndrome.

27490918

Jamilian M

2016

The Effects of Soy Isoflavones on Metabolic Status of Patients With Polycystic Ovary Syndrome.

27491227

Liang Y

2016

[Effects of Cangfu Congxian Decoction on Oxidative Stress in Polycystic Ovary Syndrome Patients].

27492704

Doggui R

2016

Immunoanalytical profile of androstenedione.

27493664

Benelli E

2016

A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women.

27498530

Bjelica A

2016

ALGORITHM OF OVULATION INDUCTION IN PATIENTS WITH POLYCISTIC OVARY SYNDROME.

27499286

Herczeg Z

2016

[Genetic and epigenetic factors of polycystic ovary syndrome].

27499648

Love JG

2016

The experiences of women with polycystic ovary syndrome on a very low-calorie diet.

27502954

Li M

2017

Serum Macroelement and Microelement Concentrations in Patients with Polycystic Ovary Syndrome: a Cross-Sectional Study.

27504851

Gawlik A

2016

Steroid Metabolomic Disease Signature of Nonsyndromic Childhood Obesity.

27504948

Rzeszowska M

2016

Anti-M?llerian hormone: a critical factor for female fertility and reproductive health.

27505055

G?bl CS

2016

To Assess the Association between Glucose Metabolism and Ectopic Lipid Content in Different Clinical Classifications of PCOS.

27505846

Messadi A

2016

Distribution of HLA DRB1 and DQB1 alleles and DRB1-DQB1 haplotypes among Bahraini women with polycystic ovary syndrome.

27506102

Okanovi? M

2016

VALPROATE, BIPOLAR DISORDER AND POLYCYSTIC OVARIAN SYNDROME.

27509101

Chen ZJ

2016

Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome.

27509107

Coutifaris C

2016

Freeze Only--An Evolving Standard in Clinical In Vitro Fertilization.

27510480

Luque-Ram?rez M

2016

Adrenal Hyperandrogenism and Polycystic Ovary Syndrome.

27510481

Spritzer PM

2016

Hirsutism in Polycystic Ovary Syndrome: Pathophysiology and Management.

27510482

Moghetti P

2016

Insulin Resistance and Polycystic Ovary Syndrome.

27510483

Muscogiuri G

2016

Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside.

27510484

Tziomalos K

2016

Cardiovascular Risk in the Different Phenotypes of Polycystic Ovary Syndrome.

27510491

Sir-Petermann T

2016

Metabolic Features Across the Female Life Span in Women with PCOS.